Fatigue is not a single measurement. Different scales can capture different experiences, and their results should not be compressed into one unqualified benefit claim. Primary study
What was reported
Sixty patients with persistent fatigue despite levothyroxine treatment were randomized to L-carnitine or placebo for 12 weeks. The mental-fatigue comparison favored L-carnitine, while overall fatigue-severity and physical-fatigue score changes were not significant. Responder and subgroup analyses added further favorable observations. Primary report
Our appraisal: retain the hierarchy and definition of improvement
A continuous score and a responder classification are different analyses. The latter depends on where the response threshold is placed. A higher proportion classified as improved can coexist with a neutral mean-score comparison, especially in a small sample.
That coexistence is not inherently contradictory, but it requires explanation. Review should establish whether thresholds and analyses were prespecified and how missing follow-up scores were handled before selecting a success percentage.
Subgroups introduce another layer of uncertainty. A favorable result in younger participants or one clinical subgroup does not prove that the effect differs from everyone else. That requires a suitable interaction analysis and consideration of multiple comparisons.
The background treatment is also essential. The experiment addressed residual symptoms during thyroid-hormone replacement, not substitution for that replacement. Its population cannot be generalized to all causes of fatigue.
The defensible conclusion is a mixed fatigue-scale result with a mental-fatigue signal that merits careful appraisal. It is not proof of broad symptom resolution or a reason to alter thyroid treatment. A publication-ready page should identify the primary outcome, retain neutral score findings, and distinguish exploratory responder or subgroup observations from the main comparison.
Frequently asked questions
Were patients already receiving levothyroxine?
Yes.
How many were randomized?
Sixty.
Did every fatigue scale improve significantly?
No.
Which domain favored L-carnitine?
The mental-fatigue score.
Are responder rates identical to mean-score changes?
No.
Does a subgroup result prove differential benefit?
Not without an appropriate interaction analysis.
Did this test replacing thyroid hormone?
No.